<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Bragt, P.C.</title>
    <link>http://repub.eur.nl/res/aut/47229/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>The involvement of free radicals and lipid peroxidation in inflammation: pharmacological implications (Doctoral Thesis)</title>
      <link>http://repub.eur.nl/res/pub/31526/</link>
      <pubDate>1980-12-03T00:00:00Z</pubDate>
      <description>In 1954, Duboulez and Dumas showed that 1 ipid peroxidation is
involved in acute inflammation. Many years later, it was recognized that
after injury prostaglandins and related substances are formed by endoperoxidation
of polyunsaturated fatty acids. Thus, dihomo-y-1 inolenic acid
and arachidonic acid are converted to prostaglandin endoperoxides by
cycle-oxygenase. These endoperoxides are then converted to the stable
prostaglandins, thromboxane, prostacycl in, hydroxy-fatty acid and malonaldehyde.
Thus, it is possible that the peroxides detected by Duboulez and
Dumas were prostaglandin endoperoxides.
The aim of our studies were to investigate whether 1 ipid peroxidation
occurs at the site of inflammation independently of the biosynthesis of
prostaglandins. This seemed likely, as fatty acid precursors are abundant
at the inflamed site and since initiators of 1 ipid peroxidation, namely free
radicals, are constantly generated and released by granulocytes and mononuclear
phagocytes, during phagocytosis.
Malonaldehyde is a stable end product of the decomposition of
endoperoxides formed during 1 ipid peroxidation, which has been used as a
monitor of the extent of 1 ipid peroxidation in chemical and biological
systems. As locally formed malonaldehyde may originate from the arachidonate
cascade and, more specifically, from the thromboxane synthetase pathway,
it was planned to investigate time-dependent changes in prostaglandin
biosynthesis, for which purpose radioactively label led arachidonic acid
was to be injected into the inflamed site. An inflammation model which allows
the accurate injection of drugs and local hormone precursors into the
inflamed site, namely the model of cannulated sponge implants in the rat,
was in routine use within our laboratory. However, the sponges do not allow
for the collection of inflammatory exudate from the granulomata around the
sponges, without surgical intervention. Therefore, an analogous model was
to be developed which permitted the collection by perfusion of inflammatory
exudate containing the radioactively labelled metabolites of arachidonic
acid</description>
    </item>
  </channel>
</rss>